Conversely, the expression of CYP21A2, the gene involved in the mineralocorticoids metabolism, was fourfold higher in non-PCOS group than that of the PCOS group (Fig. 4; P < 0.001). The gene discussed is CYP21A2; the disease is polycystic ovary syndrome.